Similar articles

• Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells.

  Sakai I, Takeuchi K, Yamauchi H, Narumi H, Fujita S. Sakai I, et al. Blood. 2002 Oct 15;100(8):2926-31. doi: 10.1182/blood-2002-01-0073. Blood. 2002. PMID: 12351404
• The suppressor of cytokine signaling-1 is constitutively expressed in chronic myeloid leukemia and correlates with poor cytogenetic response to interferon-alpha.

  Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, Cervantes F, Barrios M, Colomer D, Heiniger A, Torres A. Roman-Gomez J, et al. Haematologica. 2004 Jan;89(1):42-8. Haematologica. 2004. PMID: 14754605
• Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha.

  Yanagisawa K, Yamauchi H, Kaneko M, Kohno H, Hasegawa H, Fujita S. Yanagisawa K, et al. Blood. 1998 Jan 15;91(2):641-8. Blood. 1998. PMID: 9427720
• Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase.

  Guilhot F, Lacotte-Thierry L. Guilhot F, et al. Hematol Cell Ther. 1998 Oct;40(5):237-9. Hematol Cell Ther. 1998. PMID: 9844819 Review.
• BCR-ABL1 in leukemia: disguise master outplays riding shotgun.

  Rana A, Ali GM, Ali S, Khan A, Mansoor S, Malik S, Farooqi AA. Rana A, et al. J Cancer Res Ther. 2013 Jan-Mar;9(1):6-10. doi: 10.4103/0973-1482.110339. J Cancer Res Ther. 2013. PMID: 23575066 Review.